Phoenix Biotech Acquisition Corp.
PBAX · NASDAQ
12/31/2024 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|
| Market Cap | $290,603 | $692,999 | $683,233 |
| - Cash | $3,327 | $476 | $1,099 |
| + Debt | $1,575 | $650 | $0 |
| Enterprise Value | $288,852 | $693,174 | $682,134 |
| Revenue | $0 | $0 | $0 |
| % Growth | – | – | – |
| Gross Profit | $0 | $255 | $0 |
| % Margin | – | – | – |
| EBITDA | -$16,198 | -$5,742 | -$332 |
| % Margin | – | – | – |
| Net Income | -$11,089 | -$668 | -$316 |
| % Margin | – | – | – |
| EPS Diluted | -0.22 | -0.01 | -0.005 |
| % Growth | -2,122.2% | -115.2% | – |
| Operating Cash Flow | -$5,790 | -$1,092 | -$697 |
| Capital Expenditures | $0 | $0 | $0 |
| Free Cash Flow | -$5,790 | -$1,092 | -$697 |